{"id":"https://openalex.org/W2226551900","doi":"https://doi.org/10.1186/1750-1172-10-s1-p12","title":"Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy","display_name":"Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy","publication_year":2015,"publication_date":"2015-11-02","ids":{"openalex":"https://openalex.org/W2226551900","doi":"https://doi.org/10.1186/1750-1172-10-s1-p12","mag":"2226551900"},"language":"en","primary_location":{"id":"doi:10.1186/1750-1172-10-s1-p12","doi":"https://doi.org/10.1186/1750-1172-10-s1-p12","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-10-s1-p12","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-10-S1-P12","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-10-S1-P12","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019223420","display_name":"M\u00e1rcia Waddington\u2010Cruz","orcid":"https://orcid.org/0000-0003-4853-2236","observed_orcids":["https://orcid.org/0000-0003-4853-2236"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marcia Waddington-Cruz","raw_affiliation_strings":["Hospital Universitario Clementino, Neuromuscular Diseases Unit, 21941-913, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Clementino, Neuromuscular Diseases Unit, 21941-913, Rio de Janeiro, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080366556","display_name":"Leslie Amass","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Amass","raw_affiliation_strings":["Pfizer, Pfizer, PA 19426, Collegeville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Pfizer, PA 19426, Collegeville, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065931469","display_name":"Denis J. Keohane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denis Keohane","raw_affiliation_strings":["Pfizer, Pfizer, NY 10017, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Pfizer, NY 10017, New York, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jeffrey Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Schwartz","raw_affiliation_strings":["Pfizer, Pfizer, CT 06340, Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Pfizer, CT 06340, Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005444348","display_name":"Balarama K. Gundapaneni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balarama Gundapaneni","raw_affiliation_strings":["InVentiv Health, Statistics, MA 01803, Burlington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InVentiv Health, Statistics, MA 01803, Burlington, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111683384","display_name":"Hui Hua Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hui Hua Li","raw_affiliation_strings":["Pfizer, Pfizer, PA 19426, Collegeville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Pfizer, PA 19426, Collegeville, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019223420"],"corresponding_institution_ids":[],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":0.3944,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.59732472,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"10","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tafamidis","display_name":"tafamidis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/transthyretin-familial-amyloid-polyneuropathy","display_name":"transthyretin familial amyloid polyneuropathy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/transthyretin-stabilizers","display_name":"transthyretin stabilizers","score":0.8109999895095825},{"id":"https://openalex.org/keywords/v30m-mutation","display_name":"V30M mutation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","level":2,"score":0.9307633638381958},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7149169445037842},{"id":"https://openalex.org/C2775892965","wikidata":"https://www.wikidata.org/wiki/Q1502312","display_name":"Polyneuropathy","level":2,"score":0.6784230470657349},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5409762263298035},{"id":"https://openalex.org/C2910844529","wikidata":"https://www.wikidata.org/wiki/Q3338677","display_name":"Amyloid polyneuropathy","level":4,"score":0.5027620792388916},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42705297470092773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41744959354400635},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3655077815055847},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3431488871574402},{"id":"https://openalex.org/C2777767895","wikidata":"https://www.wikidata.org/wiki/Q4691924","display_name":"Age of onset","level":3,"score":0.12054219841957092},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09969297051429749}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1186/1750-1172-10-s1-p12","doi":"https://doi.org/10.1186/1750-1172-10-s1-p12","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-10-s1-p12","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-10-S1-P12","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3620942","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4642113","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4642113","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4642113","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet J Rare Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/1750-1172-10-s1-p12","doi":"https://doi.org/10.1186/1750-1172-10-s1-p12","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-10-s1-p12","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-10-S1-P12","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2226551900.pdf","grobid_xml":"https://content.openalex.org/works/W2226551900.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2551198464","https://openalex.org/W2605957341","https://openalex.org/W2225425721","https://openalex.org/W2501376604","https://openalex.org/W2080914865","https://openalex.org/W2588921394","https://openalex.org/W2588179459","https://openalex.org/W2131999691","https://openalex.org/W2796779108","https://openalex.org/W2038935930"],"abstract_inverted_index":{"Tafamidis":[0],"is":[1],"a":[2,190,225,285],"transthyretin":[3],"(TTR)":[4],"stabilizer":[5],"approved":[6],"to":[7,55,277,310,333],"delay":[8],"neurological":[9,52,146,323],"progression":[10,53,79,147,230,324],"associated":[11,223,325],"with":[12,88,123,189,224,316,326,339],"stage":[13,93],"1":[14,94,249],"TTR":[15],"familial":[16],"amyloid":[17],"polyneuropathy":[18],"(FAP).":[19],"A":[20],"placebo-controlled,":[21],"randomized":[22],"18-month":[23],"registration":[24,105],"trial":[25,106,128],"allowed":[26],"for":[27,49,85,133,157],"continued":[28],"evaluation":[29],"of":[30,47,58,64,76,103,116,143,178,196,199,228,243,274,280,288,301,303],"patients":[31,87,121,275],"receiving":[32],"tafamidis":[33,48,98,124,144,317],"(20":[34],"mg":[35],"oral":[36],"once-daily)":[37],"through":[38],"an":[39,304],"ongoing":[40],"open":[41],"label":[42],"extension":[43,131],"study.":[44],"The":[45,141],"effectiveness":[46],"delaying":[50,322],"long-term":[51,319],"relative":[54],"baseline":[56,205,238,278],"levels":[57],"neuropathy":[59],"impairment":[60],"at":[61,100,163,212,248,253,258,263,269],"the":[62,74,77,89,101,104,109,126,153,170,174,307,331],"start":[63,102,166,214],"treatment":[65,165,213,244,302],"has":[66],"not":[67],"been":[68],"reported":[69],"previously.":[70],"This":[71],"analysis":[72],"describes":[73],"trajectory":[75],"disease":[78,197,206,229,290],"over":[80,148,231,240],"5.5":[81,241,270],"years":[82,242,265,300],"or":[83,107,129,312],"more":[84],"71":[86],"V30M":[90,120],"mutation":[91],"and":[92,132,266,282],"TTR-FAP":[95,341],"who":[96],"received":[97],"either":[99],"after":[108,298],"switch":[110],"from":[111,237],"placebo":[112],"following":[113],"18":[114],"months":[115],"study":[117],"participation.":[118],"All":[119],"treated":[122],"in":[125,235,306,321],"original":[127],"its":[130],"whom":[134],"follow-up":[135],"data":[136,329],"were":[137,139,185],"available":[138],"included.":[140],"impact":[142],"on":[145],"time":[149],"was":[150,167,222,296],"evaluated":[151],"using":[152],"Neuropathy":[154],"Impairment":[155],"Scale":[156],"lower":[158],"limbs":[159],"(NIS-LL).":[160],"Baseline":[161],"NIS-LL":[162,210,217,236,279,308],"active":[164,176],"defined":[168,208],"as":[169,209,335,337],"last":[171],"measurement":[172],"before":[173],"first":[175],"dose":[177],"tafamidis.":[179],"Patients":[180],"(30":[181],"male,":[182],"41":[183],"female)":[184],"primarily":[186],"Caucasian":[187],"(91.5%)":[188],"mean":[191,216],"(standard":[192],"deviation":[193],"[SD])":[194],"age":[195],"onset":[198],"35.7":[200],"(11.31)":[201],"years.":[202,271],"Very":[203],"low":[204],"severity,":[207],"\u226410":[211],"(baseline":[215],"[SD]":[218],"=":[219],"4.1":[220],"[3.1]),":[221],"minimal":[226],"level":[227],"time.":[232],"Mean":[233],"change":[234],"(SD)":[239],"was:":[245],"0.6":[246],"(3.2)":[247],"year,":[250],"1.3":[251],"(3.7)":[252],"2":[254],"years,":[255,260],"2.3":[256],"(6.0)":[257],"3":[259,293],"1.7":[261],"(4.8)":[262],"4":[264],"5.3":[267],"(10.1)":[268],"Additional":[272],"categorization":[273],"according":[276],"0-5":[281],"5-10":[283],"revealed":[284],"similar":[286],"pattern":[287],"reduced":[289],"trajectory.":[291],"For":[292],"patients,":[294],"there":[295],"evidence":[297],"3-5":[299],"increase":[305],"score":[309],"30":[311],"more.":[313],"Early":[314],"intervention":[315],"provides":[318],"benefit":[320],"TTR-FAP.":[327],"These":[328],"underscore":[330],"need":[332],"intervene":[334],"early":[336],"possible":[338],"symptomatic":[340],"patients.":[342]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}